Acquisition of a multidrug-resistant phenotype with a proteasome inhibitor in multiple myeloma

Leukemia. 2009 Nov;23(11):2181-3. doi: 10.1038/leu.2009.123. Epub 2009 Jun 11.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Boronic Acids / pharmacology*
  • Bortezomib
  • Cell Line, Tumor
  • Drug Resistance, Multiple*
  • Humans
  • Multiple Myeloma / drug therapy*
  • Oligopeptides / pharmacology
  • Phenotype
  • Protease Inhibitors / pharmacology*
  • Pyrazines / pharmacology*

Substances

  • Boronic Acids
  • Oligopeptides
  • Protease Inhibitors
  • Pyrazines
  • Bortezomib
  • carfilzomib